Literature DB >> 23637303

Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.

Jesús Rodríguez-Baño1, Jesús Oteo, Adriana Ortega, Macarena Villar, M Carmen Conejo, Germán Bou, Maitane Aranzamendi-Zaldumbide, Emilia Cercenado, Mercè Gurguí, Luis Martínez-Martínez, María Merino, Alba Rivera, Antonio Oliver, Irene Weber, Alvaro Pascual, Rosa M Bartolomé, Juan José Gónzalez-López, José Campos.   

Abstract

Two hundred twelve patients with colonization/infection due to amoxicillin-clavulanate (AMC)-resistant Escherichia coli were studied. OXA-1- and inhibitor-resistant TEM (IRT)-producing strains were associated with urinary tract infections, while OXA-1 producers and chromosomal AmpC hyperproducers were associated with bacteremic infections. AMC resistance in E. coli is a complex phenomenon with heterogeneous clinical implications.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23637303      PMCID： PMC3697715          DOI： 10.1128/JCM.00999-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data.

Authors:  José Campos; Matus Ferech; Edurne Lázaro; Francisco de Abajo; Jesús Oteo; Peter Stephens; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2007-07-06       Impact factor: 5.790

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

4.  Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.

Authors:  Sofia Maraki; Elpis Mantadakis; Lambros Michailidis; George Samonis
Journal:  J Microbiol Immunol Infect       Date:  2012-07-12       Impact factor: 4.399

5.  Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.

Authors:  Jesús Rodríguez-Baño; Elisenda Miró; Macarena Villar; Alicia Coelho; Mónica Gozalo; Nuria Borrell; Germán Bou; M Carmen Conejo; Virginia Pomar; Belén Aracil; Nieves Larrosa; Jesús Agüero; Antonio Oliver; Ana Fernández; Jesús Oteo; Alvaro Pascual; Ferran Navarro
Journal:  J Infect       Date:  2011-11-23       Impact factor: 6.072

6.  Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  Adriana Ortega; Jesús Oteo; Maitane Aranzamendi-Zaldumbide; Rosa M Bartolomé; Germán Bou; Emilia Cercenado; M Carmen Conejo; Juan José González-López; Mercedes Marín; Luis Martínez-Martínez; María Merino; Ferran Navarro; Antonio Oliver; Alvaro Pascual; Alba Rivera; Jesús Rodríguez-Baño; Irene Weber; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

7.  "Collateral damage" from cephalosporin or quinolone antibiotic therapy.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2004-05-15       Impact factor: 9.079

8.  The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

Authors:  B Picard; J S Garcia; S Gouriou; P Duriez; N Brahimi; E Bingen; J Elion; E Denamur
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features.

Authors:  Jesús Rodríguez-Baño; Jesús Mingorance; Natalia Fernández-Romero; Lara Serrano; Lorena López-Cerero; Alvaro Pascual
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

10.  Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain.

Authors:  Jesús Oteo; José Campos; Edurne Lázaro; Oscar Cuevas; Silvia García-Cobos; María Pérez-Vázquez; F J de Abajo
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883
View more
  4 in total

1.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

2.  Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Authors:  V Pascual; N Alonso; M Simó; G Ortiz; M C Garcia; M Xercavins; A Rivera; M A Morera; E Miró; E Espejo; F Navarro; M Gurguí; J Pérez; M Rodríguez-Carballeira; J Garau; E Calbo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-22       Impact factor: 3.267

3.  Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.

Authors:  Fardod O'Kelly; Siobhan Kavanagh; Rustom Manecksha; John Thornhill; Jérôme P Fennell
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

4.  Clinical effectiveness and bacteriological eradication of three different Short-COurse antibiotic regimens and single-dose fosfomycin for uncomplicated lower Urinary Tract infections in adult women (SCOUT study): study protocol for a randomised clinical trial.

Authors:  Ana Garcia-Sangenís; Rosa Morros; Mercedes Aguilar-Sánchez; Laura Medina-Perucha; Alfonso Leiva; Joana Ripoll; Mar Martínez-Pecharromán; Cruz B Bartolomé-Moreno; Rosa Magallon Botaya; Jaime Marín-Cañada; José M Molero; Ana Moragas; Amelia Troncoso; Ramon Monfà; Carl Llor
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.